Adage Capital Partners’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $105M | Buy |
1,666,408
+78,858
| +5% | +$5.49M | 0.16% | 126 |
|
|
2025
Q4 | $105M | Buy |
1,587,550
+1,380,550
| +667% | +$89.3M | 0.16% | 121 |
|
|
2025
Q3 | $13.9M | Sell |
207,000
-201,689
| -49% | -$16M | 0.02% | 567 |
|
|
2025
Q2 | $35.7M | Buy |
408,689
+393,568
| +2,603% | +$30.8M | 0.06% | 308 |
|
|
2025
Q1 | $1.03M | Sell |
15,121
-540,000
| -97% | -$44.1M | ﹤0.01% | 794 |
|
|
2024
Q4 | $43.2M | Buy |
555,121
+7,175
| +1% | +$531K | 0.08% | 243 |
|
|
2024
Q3 | $36.7M | Buy |
547,946
+158,946
| +41% | +$13.1M | 0.06% | 290 |
|
|
2024
Q2 | $44.1M | Sell |
389,000
-80,160
| -17% | -$10.1M | 0.08% | 239 |
|
|
2024
Q1 | $65.1M | Sell |
469,160
-106,140
| -18% | -$13.3M | 0.12% | 182 |
|
|
2023
Q4 | $71.4M | Buy |
575,300
+189,700
| +49% | +$19.4M | 0.15% | 152 |
|
|
2023
Q3 | $36M | Sell |
385,600
-93,560
| -20% | -$10.5M | 0.08% | 257 |
|
|
2023
Q2 | $61.6M | Sell |
479,160
-220,958
| -32% | -$26.7M | 0.13% | 168 |
|
|
2023
Q1 | $81.3M | Sell |
700,118
-42,782
| -6% | -$4.79M | 0.18% | 139 |
|
|
2022
Q4 | $84.1M | Buy |
742,900
+182,900
| +33% | +$20.1M | 0.2% | 124 |
|
|
2022
Q3 | $45.1M | Buy |
560,000
+151,200
| +37% | +$12.8M | 0.11% | 198 |
|
|
2022
Q2 | $30.5M | Buy |
408,800
+4,100
| +1% | +$374K | 0.07% | 297 |
|
|
2022
Q1 | $51.8M | Sell |
404,700
-8,400
| -2% | -$919K | 0.1% | 205 |
|
|
2021
Q4 | $55.5M | Sell |
413,100
-2,000
| -0.5% | -$287K | 0.1% | 205 |
|
|
2021
Q3 | $56.8M | Sell |
415,100
-2,000
| -0.5% | -$252K | 0.11% | 194 |
|
|
2021
Q2 | $44.5M | Buy |
417,100
+70,000
| +20% | +$6.72M | 0.09% | 237 |
|
|
2021
Q1 | $31.2M | Sell |
347,100
-159,400
| -31% | -$15M | 0.06% | 319 |
|
|
2020
Q4 | $46.8M | Buy |
506,500
+77,824
| +18% | +$6.95M | 0.1% | 214 |
|
|
2020
Q3 | $44.2M | Buy |
428,676
+1,600
| +0.4% | +$167K | 0.11% | 200 |
|
|
2020
Q2 | $43.3M | Buy |
427,076
+187,076
| +78% | +$16.7M | 0.11% | 209 |
|
|
2020
Q1 | $16.2M | Buy |
+240,000
| New | +$14.9M | 0.05% | 367 |
|
|
2017
Q3 | – | Sell |
-1,200,000
| Closed | -$21.9M | – | 720 |
|
|
2017
Q2 | $21.9M | Buy |
+1,200,000
| New | +$22.2M | 0.05% | 396 |
|
|
2016
Q3 | – | Sell |
-400,000
| Closed | -$7.93M | – | 698 |
|
|
2016
Q2 | $7.93M | Buy |
+400,000
| New | +$6.81M | 0.02% | 552 |
|
|
2015
Q2 | – | Sell |
-200,000
| Closed | -$3.12M | – | 735 |
|
|
2015
Q1 | $3.12M | Buy |
+200,000
| New | +$3.02M | 0.01% | 664 |
|
Other funds holding DXCM
VCM
VPM
Adage Capital Partners's DXCM Position: Q1 2026 in Review
Adage Capital Partners increased its DexCom (DXCM) stake by 5% in Q1 2026, buying an estimated $5.49M and bringing the position to 1,666,408 shares worth $105M. The position accounts for 0.16% of the portfolio, ranked #126.
Adage Capital Partners first reported a position in DXCM in Q1 2015 and has held it in 28 quarters since. The position peaked at $105M in Q4 2025. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Adage Capital Partners held 1,666,408 shares of DexCom worth $105M as of Q1 2026.
- Adage Capital Partners bought 78,858 DexCom shares in Q1 2026, an estimated $5.49M.
- DexCom made up 0.16% of Adage Capital Partners's portfolio in Q1 2026, its #126 holding.
- Adage Capital Partners first reported a position in DexCom in Q1 2015 and has held it in 28 quarters since.
- Adage Capital Partners's DexCom position peaked at $105M in Q4 2025.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.